Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.40 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.40 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.40 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.36 |
| ▸ | CD44 | P16070 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | NSD2 | O96028 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethylene SCHEMBL27478030 | 0.96 | CA2 (0.43) | CA2CYP3A4TSHRGABRA1GABRB2 | |
| SCHEMBL9253214 | 0.85 | CYP3A4 (0.48) | CA2CYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL25696408 | 0.85 | CA2 (0.37) | CA2CYP3A4TSHRPIK3CAALDH1A1 | |
| SCHEMBL24126312 | 0.85 | CA2 (0.41) | CA2CYP3A4TSHRGABRA1GABRB2 | |
| SCHEMBL304569 | 0.82 | CA2 (0.57) | CA2TSHRGABRA1GABRB2ALDH1A1 | |
| SCHEMBL4461655 | 0.80 | CA2 (0.50) | CA2TSHRGABRA1GABRB2ALDH1A1 | |
| SCHEMBL6061735 | 0.78 | CA2 (0.32) | CA2TSHRALDH1A1TDP1MEN1 | |
| SCHEMBL6028201 | 0.78 | CD44 (0.48) | CA2CYP3A4TSHRGABRA1GABRB2 | |
| SCHEMBL70170 | 0.77 | TSHR (0.50) | CA2CYP3A4TSHRGABRA1GABRB2 | |
| SCHEMBL9607578 | 0.76 | CD44 (0.52) | CA2CYP3A4TSHRGABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114957240-B | Preparation method and application of carbonyl ring-closed arylamine fluorescent compound | 广东工业大学 | 2024-07-19 | — | — | CN | claimed |
| CN-118027031-A | Carbonyl ring-closed arylamine fluorescent compound with narrow band emission, and preparation method and application thereof | 广东工业大学 | 2024-05-14 | — | — | CN | claimed |
| CN-117003753-A | Carbonyl arylamine pi stacking fluorescent dye and preparation method thereof | 广东工业大学 | 2023-11-07 | — | — | CN | claimed |
| CN-116283984-A | Organic thermal delay fluorescent material based on di-tert-butylaniline donor and preparation method thereof | 电子科技大学 | 2023-06-23 | — | — | CN | claimed |
| CN-114957240-A | Preparation method and application of carbonyl closed-loop arylamine fluorescent compound | 广东工业大学 | 2022-08-30 | — | — | CN | claimed |
| EP-1633364-B1 | PROCESSES FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT | TEVA PHARMA (IL) | 2008-02-27 | — | — | EP | claimed |
| JP-2007517803-A | — | — | 2007-07-05 | — | — | JP | claimed |
| EP-1779852-A2 | Methods for the production of sildenafil base and citrate salt | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2007-05-02 | — | — | EP | claimed |
| EP-1633364-A2 | METHODS FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2006-03-15 | — | — | EP | claimed |
| US-20050182066-A1 | Methods for the production of sildenafil base and citrate salt | TEVA PHARMACEUTICALS USA, INC. | 2005-08-18 | — | — | US | claimed |
| WO-2005067936-A2 | METHODS FOR THE PRODUCTION OF SILDENAFIL BASE AND CITRATE SALT | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-07-28 | — | — | WO | claimed |
| CN-114685539-B | Organic compound, application thereof and organic electroluminescent device using same | Beijing Dingcai Technology Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4731689-A1 | METHOD FOR THE PRODUCTION OF THERMOPLASTIC POLYOXAZOLIDINONE | Covestro Deutschland AG (DE) | 2026-04-29 | — | — | EP | disclosed |
| CN-116283984-B | Organic thermal delay fluorescent material based on di-tert-butylaniline donor and preparation method thereof | 电子科技大学 | 2026-03-03 | — | — | CN | disclosed |
| CN-116283984-B | Organic thermal delay fluorescent material based on di-tert-butylaniline donor and preparation method thereof | 电子科技大学 | 2026-03-03 | — | — | CN | disclosed |
| EP-0328206-A2 | Method and materials to disperse solid particles in organic compounds | Canestri, Giuseppe (IT) | 1989-08-16 | — | — | EP | disclosed |
| US-4760184-A | Reacting with alcohol, olefin or diolefin in presence of alkylating catalyst of larger microspores | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1988-07-26 | — | — | US | disclosed |
| US-4745223-A | CHAIN EXTENDERS FOR POLYUREAS AND POLYURETHANES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1988-05-17 | — | — | US | disclosed |
| US-4636574-A | Process for preparing arylisothiocyanates | ETHYL CORPORATION (US) | 1987-01-13 | — | — | US | disclosed |
| EP-0177916-A1 | Mono-tertiary-alkylated toluenediamine and derivatives | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1986-04-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050182066-A1 | Methods for the production of sildenafil base and citrate salt | PDE3A, PDE5A, PDE9A | CA2 66/4885CYP3A4 377/4885TSHR 4770/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.